Granulocyte-macrophage-colony-stimulating factor: a review from preclinical development to clinical application

Transfusion. 1993 Jan;33(1):70-83. doi: 10.1046/j.1537-2995.1993.33193142315.x.

Author

J Neumanaitis¹

Affiliation

¹ West Penn Hospital, Western Pennsylvania Cancer Institute, Pittsburgh.

PMID: 8424270
DOI: 10.1046/j.1537-2995.1993.33193142315.x

No abstract available

Publication types

Review

MeSH terms

Acquired Immunodeficiency Syndrome / therapy
Animals
Antineoplastic Agents / adverse effects*
Bone Marrow Transplantation*
Breast Neoplasms / surgery
Clinical Trials as Topic
Female
Granulocyte-Macrophage Colony-Stimulating Factor / pharmacokinetics
Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology*
Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use*
Humans
Leukemia, Myeloid, Acute / surgery
Lymphoma / surgery
Myelodysplastic Syndromes / therapy
Neutropenia / chemically induced
Neutropenia / therapy*
Recombinant Proteins / pharmacokinetics
Recombinant Proteins / pharmacology
Recombinant Proteins / therapeutic use

Substances

Antineoplastic Agents
Recombinant Proteins
Granulocyte-Macrophage Colony-Stimulating Factor